Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes

Min Joo Choi, Joon-Young Song, Hee-Jin Cheong, Ji Ho Jeon, Seong Hui Kang, Eun Ju Jung, Ji Yun Noh, Woo Joo Kim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Early diagnosis of pneumococcal pneumonia facilitates appropriate antibiotic therapy. The urinary antigen test (UAT) is known to be useful for the diagnosis of pneumococcal pneumonia. This study aimed to evaluate the usefulness of UAT in the 13-valent pneumococcal conjugated vaccine (PCV13) era. Community-acquired pneumonia (CAP) cases aged ≥19 years were reviewed retrospectively. This study evaluated the utility of Streptococcus pneumoniae UAT (BinaxNOW® assay) for diagnosis of pneumococcal CAP, and the relation of the UAT positive rate to age, comorbidities, pneumonia severity, and pneumococcal serotypes. Among 752 microbiologically identified CAP cases, S. pneumoniae (36.7%) was the most common isolate, and of those cases, 56.4% were positive for UAT. UAT positivity varied by pneumococcal serotype (serotype 3, 50%; 9V/9A, 85%; 11A/11E, 54%; 14, 36.4%; 19A, 50%; and 23F, 37.5%), and was significantly increased since 2012, two years after introduction of PCV13. The positive rate of UAT was significantly related to CRP level (P = 0.007) and lobar pneumonia (P = 0.006), but not to age, co-morbidities or prior antibiotic therapy. In conclusion, urinary antigen detection varied depending on the S. pneumoniae serotype. In the PCV13 era, the serotype distribution of pneumococcal pneumonia may be changing, and the clinical usefulness of UAT needs to be monitored. The positive rate of UAT may be influenced by a localized bacterial burden and host reactions.

Original languageEnglish
Pages (from-to)672-679
Number of pages8
JournalJournal of Infection and Chemotherapy
Volume21
Issue number9
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

Antigens
Pneumococcal Pneumonia
Pneumonia
Streptococcus pneumoniae
Serogroup
Anti-Bacterial Agents
Comorbidity
Early Diagnosis
Morbidity
Therapeutics

Keywords

  • Diagnosis
  • Pneumococcal infections
  • Pneumonia
  • Streptococcus pneumonia

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes. / Choi, Min Joo; Song, Joon-Young; Cheong, Hee-Jin; Jeon, Ji Ho; Kang, Seong Hui; Jung, Eun Ju; Noh, Ji Yun; Kim, Woo Joo.

In: Journal of Infection and Chemotherapy, Vol. 21, No. 9, 01.09.2015, p. 672-679.

Research output: Contribution to journalArticle

@article{fbc0428913544ade92e09b934aa7dfae,
title = "Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes",
abstract = "Early diagnosis of pneumococcal pneumonia facilitates appropriate antibiotic therapy. The urinary antigen test (UAT) is known to be useful for the diagnosis of pneumococcal pneumonia. This study aimed to evaluate the usefulness of UAT in the 13-valent pneumococcal conjugated vaccine (PCV13) era. Community-acquired pneumonia (CAP) cases aged ≥19 years were reviewed retrospectively. This study evaluated the utility of Streptococcus pneumoniae UAT (BinaxNOW{\circledR} assay) for diagnosis of pneumococcal CAP, and the relation of the UAT positive rate to age, comorbidities, pneumonia severity, and pneumococcal serotypes. Among 752 microbiologically identified CAP cases, S. pneumoniae (36.7{\%}) was the most common isolate, and of those cases, 56.4{\%} were positive for UAT. UAT positivity varied by pneumococcal serotype (serotype 3, 50{\%}; 9V/9A, 85{\%}; 11A/11E, 54{\%}; 14, 36.4{\%}; 19A, 50{\%}; and 23F, 37.5{\%}), and was significantly increased since 2012, two years after introduction of PCV13. The positive rate of UAT was significantly related to CRP level (P = 0.007) and lobar pneumonia (P = 0.006), but not to age, co-morbidities or prior antibiotic therapy. In conclusion, urinary antigen detection varied depending on the S. pneumoniae serotype. In the PCV13 era, the serotype distribution of pneumococcal pneumonia may be changing, and the clinical usefulness of UAT needs to be monitored. The positive rate of UAT may be influenced by a localized bacterial burden and host reactions.",
keywords = "Diagnosis, Pneumococcal infections, Pneumonia, Streptococcus pneumonia",
author = "Choi, {Min Joo} and Joon-Young Song and Hee-Jin Cheong and Jeon, {Ji Ho} and Kang, {Seong Hui} and Jung, {Eun Ju} and Noh, {Ji Yun} and Kim, {Woo Joo}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.jiac.2015.06.003",
language = "English",
volume = "21",
pages = "672--679",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "9",

}

TY - JOUR

T1 - Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes

AU - Choi, Min Joo

AU - Song, Joon-Young

AU - Cheong, Hee-Jin

AU - Jeon, Ji Ho

AU - Kang, Seong Hui

AU - Jung, Eun Ju

AU - Noh, Ji Yun

AU - Kim, Woo Joo

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Early diagnosis of pneumococcal pneumonia facilitates appropriate antibiotic therapy. The urinary antigen test (UAT) is known to be useful for the diagnosis of pneumococcal pneumonia. This study aimed to evaluate the usefulness of UAT in the 13-valent pneumococcal conjugated vaccine (PCV13) era. Community-acquired pneumonia (CAP) cases aged ≥19 years were reviewed retrospectively. This study evaluated the utility of Streptococcus pneumoniae UAT (BinaxNOW® assay) for diagnosis of pneumococcal CAP, and the relation of the UAT positive rate to age, comorbidities, pneumonia severity, and pneumococcal serotypes. Among 752 microbiologically identified CAP cases, S. pneumoniae (36.7%) was the most common isolate, and of those cases, 56.4% were positive for UAT. UAT positivity varied by pneumococcal serotype (serotype 3, 50%; 9V/9A, 85%; 11A/11E, 54%; 14, 36.4%; 19A, 50%; and 23F, 37.5%), and was significantly increased since 2012, two years after introduction of PCV13. The positive rate of UAT was significantly related to CRP level (P = 0.007) and lobar pneumonia (P = 0.006), but not to age, co-morbidities or prior antibiotic therapy. In conclusion, urinary antigen detection varied depending on the S. pneumoniae serotype. In the PCV13 era, the serotype distribution of pneumococcal pneumonia may be changing, and the clinical usefulness of UAT needs to be monitored. The positive rate of UAT may be influenced by a localized bacterial burden and host reactions.

AB - Early diagnosis of pneumococcal pneumonia facilitates appropriate antibiotic therapy. The urinary antigen test (UAT) is known to be useful for the diagnosis of pneumococcal pneumonia. This study aimed to evaluate the usefulness of UAT in the 13-valent pneumococcal conjugated vaccine (PCV13) era. Community-acquired pneumonia (CAP) cases aged ≥19 years were reviewed retrospectively. This study evaluated the utility of Streptococcus pneumoniae UAT (BinaxNOW® assay) for diagnosis of pneumococcal CAP, and the relation of the UAT positive rate to age, comorbidities, pneumonia severity, and pneumococcal serotypes. Among 752 microbiologically identified CAP cases, S. pneumoniae (36.7%) was the most common isolate, and of those cases, 56.4% were positive for UAT. UAT positivity varied by pneumococcal serotype (serotype 3, 50%; 9V/9A, 85%; 11A/11E, 54%; 14, 36.4%; 19A, 50%; and 23F, 37.5%), and was significantly increased since 2012, two years after introduction of PCV13. The positive rate of UAT was significantly related to CRP level (P = 0.007) and lobar pneumonia (P = 0.006), but not to age, co-morbidities or prior antibiotic therapy. In conclusion, urinary antigen detection varied depending on the S. pneumoniae serotype. In the PCV13 era, the serotype distribution of pneumococcal pneumonia may be changing, and the clinical usefulness of UAT needs to be monitored. The positive rate of UAT may be influenced by a localized bacterial burden and host reactions.

KW - Diagnosis

KW - Pneumococcal infections

KW - Pneumonia

KW - Streptococcus pneumonia

UR - http://www.scopus.com/inward/record.url?scp=84939574393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939574393&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2015.06.003

DO - 10.1016/j.jiac.2015.06.003

M3 - Article

VL - 21

SP - 672

EP - 679

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 9

ER -